Skip to main content

Table 1 Demographic and clinical characteristics

From: Associations of thyroid hormone serum levels with in-vivo Alzheimer’s disease pathologies

  CN (n = 148)
Age (years) 68.93 ± 7.85
Education (years) 11.67 ± 4.85
Gender, female (%) 92 (62.2)
CDR 0
APOE ε4 allele(+) (%) 25 (16.9)
HRSD 0.86 ± 1.60
VRS 1.07 ± 0.92
Neuropsychological testsa
 MMSE score 26.94 ± 2.58
 Animal fluency 16.22 ± 4.70
 Boston naming 12.27 ± 2.37
 Word list learning 20.15 ± 4.15
 Constructional praxis 10.06 ± 1.37
 Word list recall 6.76 ± 1.83
 Word list recognition 9.24 ± 1.04
 Constructional recall 7.46 ± 2.80
Global amyloid burden (SUVR) 1.16 ± 0.23
Amyloid positivity (%) 16 (10.8)
T3 (mg/dl) 103.84 ± 17.34
Free T3 (pg/ml) 3.11 ± 0.34
Free T4 (ng/dl) 1.17 ± 0.16
TSH (μIU/ml) 2.36 ± 1.57
  1. Data for continuous variables presented as a mean ± SD. Categorical variables presented as N (%)
  2. APOE apolipoprotein E, CDR Clinical Dementia Rating, CN cognitively normal, HRSD Hamilton Depression Rating Score, VRS vascular risk score, MMSE Mini-mental State Examination, SUVR standardized uptake value ratio, T3 triiodothyronine, T4 thyroxine, TSH thyroid-stimulating hormone
  3. a n = 147